rs371666396
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_144573.4(NEXN):c.864G>T(p.Met288Ile) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000248 in 1,613,530 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_144573.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152016Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000404 AC: 1AN: 247520Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 134688
GnomAD4 exome AF: 0.00000205 AC: 3AN: 1461514Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727054
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152016Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74228
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant classified as Uncertain Significance - Favor Pathogenic. The p.Met288Ile variant in NEXN has not been reported in individuals with cardiomyopathy, but h as been identified in 1/65588 European chromosomes by the Exome Aggregation Cons ortium (ExAC, http://exac.broadinstitute.org; dbSNP rs371666396). This variant i s located in the last base of the exon, which is part of the 5? splice region. C omputational tools do suggest an impact to splicing, though this information is not predictive enough to determine pathogenicity. Although this variant is predi cted to disrupt splicing, the NEXN gene has not been widely studied and the spec trum of variants leading to disease is not well-defined. Loss of NEXN function h as been shown to cause DCM in zebrafish (Hassel 2009) and several predicted loss -of-function variants have been reported in individuals with a wide range of phe notypes including ASD, HCM, and DCM with LVNC, VT, and/or MVP (LMM unpublished d ata, Syrmou 2013, Pugh 2014); however, it remains unclear if one or both copies of the gene must be affected to cause disease (Hassel 2009, LMM unpublished data ). In summary, while there is some suspicion for a pathogenic role, the clinical significance of the p.Met288Ile variant is uncertain. -
Cardiovascular phenotype Uncertain:1
The c.864G>T variant (also known as p.M288I), located in coding exon 7 of the NEXN gene, results from a G to T substitution at nucleotide position 864. The amino acid change results in methionine to isoleucine at codon 288, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -
Dilated cardiomyopathy 1CC;C3151267:Hypertrophic cardiomyopathy 20 Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at